Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 7: Recent Key NMPA/CDE Policies Summary
Release time：2026-07-08
share:
Previous article：Issue 8: Quick Look at NMPA/CDE Regulatory Updates for Jan-Feb 2026
next article：Issue 6: Focusing on regulatory updates in generics, new drug development, and more
Back to list
You may also want to read
Congratulations to the QC department of Leecan for receiving high recognition in the provincial-level capability verification!
2024.12.25
Nanjing Leecan production base was inaugurated victoriously!
2022.08.01
The Researcher Conference for the Phase III Clinical Trial of Beclometasone Furoate Inhalation Aerosol was successfully held
2025.11.06
